Similar articles for PMID: 17693187

Year	Number of Results
1983	2
1987	3
1988	2
1989	2
1991	1
1992	4
1995	2
1996	5
1997	13
1998	6
1999	7
2000	5
2001	25
2002	14
2003	19
2004	36
2005	51
2006	54
2007	72
2008	28
2009	19
2010	8
2011	11
2012	14
2013	7
2014	5
2015	5
2016	5
2017	2
2018	2
2019	5
2020	7
2021	7
2022	3
2023	3
2024	0

1

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.

Scaruffi P, Coco S, Cifuentes F, Albino D, Nair M, Defferrari R, Mazzocco K, Tonini GP. Scaruffi P, et al. Cancer Genet Cytogenet. 2007 Aug;177(1):20-9. doi: 10.1016/j.cancergencyto.2007.05.002. Cancer Genet Cytogenet. 2007. PMID: 17693187

2

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.

Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, Simon T, Berthold F. Spitz R, et al. Genes Chromosomes Cancer. 2006 Dec;45(12):1130-42. doi: 10.1002/gcc.20376. Genes Chromosomes Cancer. 2006. PMID: 16958102

3

Origin and functional significance of large-scale chromosomal imbalances in neuroblastoma.

Stallings RL. Stallings RL. Cytogenet Genome Res. 2007;118(2-4):110-5. doi: 10.1159/000108291. Cytogenet Genome Res. 2007. PMID: 18000361

4

Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, Nair P, Brothman AR, Stallings RL. Selzer RR, et al. Genes Chromosomes Cancer. 2005 Nov;44(3):305-19. doi: 10.1002/gcc.20243. Genes Chromosomes Cancer. 2005. PMID: 16075461

5

Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.

Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM. Mosse YP, et al. Genes Chromosomes Cancer. 2007 Oct;46(10):936-49. doi: 10.1002/gcc.20477. Genes Chromosomes Cancer. 2007. PMID: 17647283

6

High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.

Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, Lim G, Moldovan L, Zielenska M. Squire JA, et al. Genes Chromosomes Cancer. 2003 Nov;38(3):215-25. doi: 10.1002/gcc.10273. Genes Chromosomes Cancer. 2003. PMID: 14506695

7

Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

McArdle L, McDermott M, Purcell R, Grehan D, O'Meara A, Breatnach F, Catchpoole D, Culhane AC, Jeffery I, Gallagher WM, Stallings RL. McArdle L, et al. Carcinogenesis. 2004 Sep;25(9):1599-609. doi: 10.1093/carcin/bgh173. Epub 2004 Apr 16. Carcinogenesis. 2004. PMID: 15090470 Review.

8

Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.

Pezzolo A, Rossi E, Gimelli S, Parodi F, Negri F, Conte M, Pistorio A, Sementa A, Pistoia V, Zuffardi O, Gambini C. Pezzolo A, et al. Neuro Oncol. 2009 Apr;11(2):192-200. doi: 10.1215/15228517-2008-086. Epub 2008 Oct 15. Neuro Oncol. 2009. PMID: 18923191 Free PMC article.

9

Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F. Spitz R, et al. Clin Cancer Res. 2003 Jan;9(1):52-8. Clin Cancer Res. 2003. PMID: 12538451

10

Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F. Spitz R, et al. Clin Cancer Res. 2003 Oct 15;9(13):4835-40. Clin Cancer Res. 2003. PMID: 14581355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

432 results

Results by year